Skip to content

Clinical trials

Enrolling by invitation Attention Deficit Disorder with Hyperactivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Status: Enrolling by invitation Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Qbtech AB2
San Diego State University2
Axsome Therapeutics, Inc.1
Boston Children's Hospital1
Psyrin Inc.1
University of California, Davis1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity9
Autism Spectrum Disorder1
Bipolar Disorder1
Down Syndrome1
Fragile X Syndrome1
Generalized Anxiety Disorder1
Intellectual Disability1
Obsessive-Compulsive Disorder1
Stress Disorders, Post-Traumatic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.